Technical Analysis for CPIX - Cumberland Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 1.12 0.00% 0.00
CPIX closed unchanged on Friday, November 1, 2024, on 58 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 5
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Gapped Up Strength 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Lower Bollinger Band Walk Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Gap Up Partially Closed about 22 hours ago
Gapped Up (Partial) 1 day ago
Rose Above Lower Bollinger Band 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cumberland Pharmaceuticals Inc. Description

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Pain Drugs Clinical Development Medication Analgesics Gastroenterology Constipation Fever Hepatotoxins Paracetamol Prescription Product Prescription Products Hepatorenal Syndrome Treatment Of Hepatorenal Syndrome

Is CPIX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.3587
52 Week Low 1.07
Average Volume 22,123
200-Day Moving Average 1.58
50-Day Moving Average 1.27
20-Day Moving Average 1.24
10-Day Moving Average 1.21
Average True Range 0.09
RSI (14) 31.51
ADX 39.13
+DI 22.66
-DI 14.25
Chandelier Exit (Long, 3 ATRs) 1.14
Chandelier Exit (Short, 3 ATRs) 1.35
Upper Bollinger Bands 1.35
Lower Bollinger Band 1.14
Percent B (%b) -0.09
BandWidth 16.64
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.012
Fundamentals Value
Market Cap 16.69 Million
Num Shares 14.9 Million
EPS -0.17
Price-to-Earnings (P/E) Ratio -6.59
Price-to-Sales 0.80
Price-to-Book 0.88
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.24
Resistance 3 (R3) 1.24 1.19 1.22
Resistance 2 (R2) 1.19 1.16 1.20 1.21
Resistance 1 (R1) 1.16 1.14 1.14 1.16 1.21
Pivot Point 1.11 1.11 1.10 1.12 1.11
Support 1 (S1) 1.08 1.08 1.06 1.08 1.03
Support 2 (S2) 1.03 1.06 1.04 1.03
Support 3 (S3) 1.00 1.03 1.02
Support 4 (S4) 1.00